Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Enovis Corporation stock logo
ENOV
Enovis
$33.03
-1.8%
$32.96
$28.83
$49.83
$1.92B1.7890,920 shs912,721 shs
iRadimed Corporation stock logo
IRMD
iRadimed
$59.02
-4.5%
$56.56
$42.34
$63.29
$785.79M0.9144,065 shs57,917 shs
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$85.27
-1.6%
$78.14
$40.67
$87.16
$4.37B-2.63790,302 shs506,146 shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$125.17
-3.1%
$123.02
$55.00
$177.37
$4.37B2.061.37 million shs699,454 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Enovis Corporation stock logo
ENOV
Enovis
-1.84%+5.33%+3.90%+7.96%-26.34%
iRadimed Corporation stock logo
IRMD
iRadimed
-4.54%-1.29%-2.45%+21.27%+34.87%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-1.58%+1.78%+12.93%+44.43%+108.43%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-2.76%-6.60%-9.98%+84.21%-17.84%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Enovis Corporation stock logo
ENOV
Enovis
3.5369 of 5 stars
3.43.00.00.03.21.71.9
iRadimed Corporation stock logo
IRMD
iRadimed
3.8969 of 5 stars
2.52.02.54.40.03.31.9
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
4.7613 of 5 stars
4.52.00.04.63.22.50.6
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
1.5196 of 5 stars
1.42.00.00.02.22.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Enovis Corporation stock logo
ENOV
Enovis
2.80
Moderate Buy$58.0075.60% Upside
iRadimed Corporation stock logo
IRMD
iRadimed
3.00
Buy$72.0021.99% Upside
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3.09
Buy$107.1025.60% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.80
Moderate Buy$127.331.73% Upside

Current Analyst Ratings Breakdown

Latest IRMD, TMDX, SLNO, and ENOV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/23/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$110.00
6/17/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$130.00 ➝ $150.00
6/17/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
6/4/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$125.00 ➝ $145.00
6/3/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
5/14/2025
Enovis Corporation stock logo
ENOV
Enovis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$75.00 ➝ $70.00
5/9/2025
Enovis Corporation stock logo
ENOV
Enovis
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$62.00 ➝ $55.00
5/9/2025
Enovis Corporation stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$64.00 ➝ $57.00
5/9/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$125.00 ➝ $130.00
5/9/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$105.00 ➝ $125.00
(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Enovis Corporation stock logo
ENOV
Enovis
$2.11B0.90$18.87 per share1.75$45.10 per share0.73
iRadimed Corporation stock logo
IRMD
iRadimed
$73.24M10.25$1.51 per share39.06$6.85 per share8.62
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/A$5.68 per shareN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$441.54M9.59$1.59 per share78.52$6.81 per share18.38
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Enovis Corporation stock logo
ENOV
Enovis
-$825.49M-$13.95N/A10.35N/A-37.65%5.99%3.44%8/6/2025 (Estimated)
iRadimed Corporation stock logo
IRMD
iRadimed
$19.23M$1.5538.0829.51N/A26.33%23.28%20.59%7/30/2025 (Estimated)
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$175.85M-$4.62N/AN/AN/AN/A-77.52%-63.44%8/6/2025 (Estimated)
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$35.46M$1.3692.0487.53N/A10.03%21.88%6.15%7/30/2025 (Estimated)

Latest IRMD, TMDX, SLNO, and ENOV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.48N/AN/AN/A$146.64 millionN/A
5/8/2025Q1 2025
Enovis Corporation stock logo
ENOV
Enovis
$0.74$0.81+$0.07-$0.98$558.80 million$558.83 million
5/8/2025Q1 2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.29$0.70+$0.41$0.70$123.39 million$143.54 million
5/7/2025Q1 2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$1.14-$0.95+$0.19-$0.95N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Enovis Corporation stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
iRadimed Corporation stock logo
IRMD
iRadimed
$0.681.15%N/A43.87%1 Years
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A

Latest IRMD, TMDX, SLNO, and ENOV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/5/2025
iRadimed Corporation stock logo
IRMD
iRadimed
quarterly$0.171.3%5/20/20255/20/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Enovis Corporation stock logo
ENOV
Enovis
0.52
2.55
1.32
iRadimed Corporation stock logo
IRMD
iRadimed
N/A
8.87
7.62
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
0.21
19.64
19.64
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
1.92
9.10
8.32

Institutional Ownership

CompanyInstitutional Ownership
Enovis Corporation stock logo
ENOV
Enovis
98.45%
iRadimed Corporation stock logo
IRMD
iRadimed
92.34%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
97.42%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
Enovis Corporation stock logo
ENOV
Enovis
2.70%
iRadimed Corporation stock logo
IRMD
iRadimed
36.80%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
6.40%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
7.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Enovis Corporation stock logo
ENOV
Enovis
7,36757.12 million55.58 millionOptionable
iRadimed Corporation stock logo
IRMD
iRadimed
11012.72 million8.04 millionOptionable
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3050.39 million47.17 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
21033.82 million31.46 millionOptionable

Recent News About These Companies

TMDX - TransMedics Group Inc Executives - Morningstar
Analyzing TransMedics Group (NASDAQ:TMDX) and Teleflex (NYSE:TFX)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Enovis stock logo

Enovis NYSE:ENOV

$33.03 -0.62 (-1.84%)
As of 07/7/2025 03:59 PM Eastern

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

iRadimed stock logo

iRadimed NASDAQ:IRMD

$59.02 -2.78 (-4.50%)
As of 07/7/2025 04:00 PM Eastern

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Soleno Therapeutics stock logo

Soleno Therapeutics NASDAQ:SLNO

$85.27 -1.38 (-1.59%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$85.23 -0.04 (-0.05%)
As of 07/7/2025 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

TransMedics Group stock logo

TransMedics Group NASDAQ:TMDX

$125.17 -4.02 (-3.11%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$125.12 -0.05 (-0.04%)
As of 07/7/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.